Treatment modalities in recurrent miscarriages without diagnosis

Seminars in Reproductive Medicine

Volumn 32, Issue 4, 2014, Pages 319-322

  Whitley, Kari A ^a   Ural, Serdar H ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

miscarriage without diagnosis; recurrent miscarriage; treatment for recurrent miscarriage; unexplained miscarriage

Indexed keywords

ACETYLSALICYLIC ACID; CHORIONIC GONADOTROPIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; PROGESTERONE;

ARTICLE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HUMAN; PHYSIOTHERAPY; RECURRENT ABORTION; RELAXATION TRAINING; STRESS MANAGEMENT; SUPPLEMENTATION; SUPPORT GROUP; ABORTION, HABITUAL; FEMALE; PREGNANCY; RISK FACTOR; TREATMENT OUTCOME;

ABORTION, HABITUAL; FEMALE; HUMANS; PREGNANCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84902381092     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0034-1375185     Document Type: Article

References (33)

1. Rai R., Regan L. Recurrent miscarriage. Lancet: 2006; 368 9535 601 611 (Pubitemid 44209184)
2. Kline J. Conception to birth-epidemiology of prenatal development. Monographs in Epidemiology and Biostatistics. Oxford Oxford University Press: 1989
3. Wilcox A. J., Weinberg C. R., O'Connor J. F., et al. Incidence of early loss of pregnancy. N Engl J Med: 1988; 319 4 189 194
4. Chard T. Frequency of implantation and early pregnancy loss in natural cycles. Baillieres Clin Obstet Gynaecol: 1991; 5 1 179 189
5. Stirrat G. M. Recurrent miscarriage. Lancet: 1990; 336 8716 673 675
6. Stephenson M. D., Awartani K. A., Robinson W. P. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod: 2002; 17 2 446 451 (Pubitemid 34168456)
7. Greenwold N., Jauniaux E. Collection of villous tissue under ultrasound guidance to improve the cytogenetic study of early pregnancy failure. Hum Reprod: 2002; 17 2 452 456 (Pubitemid 34168457)
8. Toth B., Jeschke U., Rogenhofer N., et al. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol: 2010; 85 1 25 32
9. Habayeb O. M., Konje J. C. The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome. Hum Reprod: 2004; 19 12 2952 2958 (Pubitemid 40028972)
10. Practice Committee of the American Society for Reproductive Medicine Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril: 2012; 98 5 1103 1111
11. Liddell H. S., Pattison N. S., Zanderigo A. Recurrent miscarriage-outcome after supportive care in early pregnancy. Aust N Z J Obstet Gynaecol: 1991; 31 4 320 322
12. Clifford K., Rai R., Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod: 1997; 12 2 387 389 (Pubitemid 27129408)
13. Musters A. M., Taminiau-Bloem E. F., van den Boogaard E., van der Veen F., Goddijn M. Supportive care for women with unexplained recurrent miscarriage: patients' perspectives. Hum Reprod: 2011; 26 4 873 877
14. Togas T., Haya M. A. Management of couples with recurrent pregnancy loss. In: Falk S. J., ed. UpToDate. Waltham, MA UpToDate: 2013
15. Coomarasamy A., Truchanowicz E. G., Rai R. Does first trimester progesterone prophylaxis increase the live birth rate in women with unexplained recurrent miscarriages? BMJ: 2011; 342 d1914
16. Swyer G. I., Daley D. Progesterone implantation in habitual abortion. BMJ: 1953; 1 4819 1073 1077
17. Goldstein P., Berrier J., Rosen S., Sacks H. S., Chalmers T. C. A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol: 1989; 96 3 265 274 (Pubitemid 19093249)
18. Hussain M., El-Hakim S., Cahill D. J. Progesterone supplementation in women with otherwise unexplained recurrent miscarriages. J Hum Reprod Sci: 2012; 5 3 248 251
19. Haas D. M., Ramsey P. S. Progestogen for preventing miscarriage. Cochrane Database Syst Rev: 2013; 10 CD003511
20. Csapo A. I., Pulkkinen M. O., Ruttner B., Sauvage J. P., Wiest W. G. The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies. Am J Obstet Gynecol: 1972; 112 8 1061 1067
21. Yan J., Liu F., Yuan X., Saravelos S. H., Cocksedge K., Li T. C. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage. Reprod Biomed Online: 2013; 26 2 138 141
22. Ogasawara M., Kajiura S., Katano K., Aoyama T., Aoki K. Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies? Fertil Steril: 1997; 68 5 806 809 (Pubitemid 27506091)
23. Scott J. R., Pattison N. Human chorionic gonadotrophin for recurrent miscarriage. Cochrane Database Syst Rev: 2000; 2 CD000101
24. Morley L. C., Simpson N., Tang T. Human chorionic gonadotrophin (hCG) for preventing miscarriage. Cochrane Database Syst Rev: 2013; 1 CD008611
25. Rai R., Backos M., Baxter N., Chilcott I., Regan L. Recurrent miscarriage-an aspirin a day? Hum Reprod: 2000; 15 10 2220 2223
26. Kaandorp S. P., Goddijn M., van der Post J. AM., et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med: 2010; 362 17 1586 1596
27. Scarpellini F., Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod: 2009; 24 11 2703 2708
28. Michimata T., Sakai M., Miyazaki S., et al. Decrease of T-helper 2 and T-cytotoxic 2 cells at implantation sites occurs in unexplained recurrent spontaneous abortion with normal chromosomal content. Hum Reprod: 2003; 18 7 1523 1528 (Pubitemid 36840964)
29. Kiprov D. D., Nachtigall R. D., Weaver R. C., Jacobson A., Main E. K., Garovoy M. R. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol: 1996; 36 4 228 234 (Pubitemid 26343429)
30. Perricone R., Di Muzio G., Perricone C., et al. High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins. Am J Reprod Immunol: 2006; 55 3 232 239 (Pubitemid 43329500)
31. Bansal A. S., Bajardeen B., Thum M. Y. The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. J Reprod Immunol: 2012; 93 1 41 51
32. Ata B., Tan S. L., Shehata F., et al. A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertil Steril: 2011; 95 3 1080 1085.e1-2
33. Daya S., Gunby J., Porter F., Scott J., Clark D. A. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage. Hum Reprod Update: 1999; 5 5 475 482 (Pubitemid 29512133)